메뉴 건너뛰기




Volumn 92, Issue 1, 2009, Pages 27-34

Funding and access to high cost medicines in public hospitals in Australia: Decision-makers' perspectives

Author keywords

Australia; High cost medicines; Priority setting; Public hospitals

Indexed keywords

ARTICLE; AUSTRALIA; DRUG COST; FUNDING; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HOSPITAL ADMINISTRATOR; HOSPITAL CARE; MANAGER; PHARMACEUTICAL CARE; PUBLIC HOSPITAL; RESOURCE ALLOCATION; SEMI STRUCTURED INTERVIEW;

EID: 67651015245     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2009.02.001     Document Type: Article
Times cited : (16)

References (40)
  • 2
    • 33847330170 scopus 로고    scopus 로고
    • Provision of pharmaceuticals in Australian hospitals: equity of access?
    • Gallego G., Taylor S.J., and Brien J.A. Provision of pharmaceuticals in Australian hospitals: equity of access?. Pharmacy World and Science 29 (2007) 47-50
    • (2007) Pharmacy World and Science , vol.29 , pp. 47-50
    • Gallego, G.1    Taylor, S.J.2    Brien, J.A.3
  • 4
    • 67651023556 scopus 로고    scopus 로고
    • Victorian Government Department of Human Services. Australian health care agreement between the Commonwealth Government and the State of Victoria 2003-2008. Victorian Government Department of Human Services. http://www.health.vic.gov.au/pfg2002/sectiona.pdf [Accessed 20 August 2004.
    • Victorian Government Department of Human Services. Australian health care agreement between the Commonwealth Government and the State of Victoria 2003-2008. Victorian Government Department of Human Services. http://www.health.vic.gov.au/pfg2002/sectiona.pdf [Accessed 20 August 2004.
  • 5
    • 0033127897 scopus 로고    scopus 로고
    • Incremental change in the Australian health care system
    • Hall J. Incremental change in the Australian health care system. Health Affairs (Millwood) 18 (1999) 95-110
    • (1999) Health Affairs (Millwood) , vol.18 , pp. 95-110
    • Hall, J.1
  • 7
    • 67651008103 scopus 로고    scopus 로고
    • Australian Government Department of Health and Ageing, Australian Government Department of Health and Ageing, Accessed 29 January 2009
    • Australian Government Department of Health and Ageing. Highly specialised drugs program. Australian Government Department of Health and Ageing. http://www.pbs.gov.au/html/healthpro/browseby/section100?subbook=HS [Accessed 29 January 2009].
    • Highly specialised drugs program
  • 10
    • 67651023554 scopus 로고    scopus 로고
    • NSW Department of Health. Circular no. 2004/73. Funding arrangements for outpatient use of high cost drugs not funded by the commonwealth [Accessed 2009].
    • NSW Department of Health. Circular no. 2004/73. Funding arrangements for outpatient use of high cost drugs not funded by the commonwealth [Accessed 2009].
  • 14
    • 67651020642 scopus 로고    scopus 로고
    • Accessed 2003
    • South East Health. About SEH. http://www.sesahs.nsw.gov.au/aboutus.asp [Accessed 2003].
    • South East Health. About SEH
  • 15
    • 0005014518 scopus 로고    scopus 로고
    • Qualitative methods in health and health service research
    • Mays N., and Pope C. (Eds), BMJ Publishing Group, London p. 1-9
    • Pope C., and Mays N. Qualitative methods in health and health service research. In: Mays N., and Pope C. (Eds). Qualitative research in health care (1996), BMJ Publishing Group, London p. 1-9
    • (1996) Qualitative research in health care
    • Pope, C.1    Mays, N.2
  • 18
    • 0022771578 scopus 로고
    • Bentham in a box: technology assessment and health care allocation
    • Jonsen A.R. Bentham in a box: technology assessment and health care allocation. Law, Medicine & Health Care 14 (1986) 172-174
    • (1986) Law, Medicine & Health Care , vol.14 , pp. 172-174
    • Jonsen, A.R.1
  • 20
    • 0033550686 scopus 로고    scopus 로고
    • Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold
    • Foy R., So J., Rous E., and Scarffe J.H. Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold. British Medical Journal 318 (1999) 456-459
    • (1999) British Medical Journal , vol.318 , pp. 456-459
    • Foy, R.1    So, J.2    Rous, E.3    Scarffe, J.H.4
  • 21
    • 0037344399 scopus 로고    scopus 로고
    • Very high cost treatment for a single individual-a case report
    • Wight J., and Richards M. Very high cost treatment for a single individual-a case report. Journal of Public Health Medicine 25 (2003) 4-7
    • (2003) Journal of Public Health Medicine , vol.25 , pp. 4-7
    • Wight, J.1    Richards, M.2
  • 22
    • 18744379133 scopus 로고    scopus 로고
    • Patients' views of priority setting for new medicines. A qualitative study of patients with rheumatoid arthritis
    • Lindblad A.K., Hartzema A.G., Jansson L., and Feltelius N. Patients' views of priority setting for new medicines. A qualitative study of patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 31 (2002) 324-329
    • (2002) Scandinavian Journal of Rheumatology , vol.31 , pp. 324-329
    • Lindblad, A.K.1    Hartzema, A.G.2    Jansson, L.3    Feltelius, N.4
  • 23
    • 84857189236 scopus 로고    scopus 로고
    • The Pharmaceutical Management Agency PHARMAC, December, Accessed January 2007
    • The Pharmaceutical Management Agency (PHARMAC). How should high cost medicines be funded? Public consultation, December 2006 http://www.pharmac.govt.nz/highcostmeds.asp [Accessed January 2007].
    • (2006) How should high cost medicines be funded? Public consultation
  • 24
    • 67651042367 scopus 로고    scopus 로고
    • Queensland Government Queensland Health, Availability of pharmaceuticals. Available from:, Accessed 19 January 2009
    • Queensland Government (Queensland Health). Queensland health policy/guidelines. Availability of pharmaceuticals. Available from: http://www.health.qld.gov.au/qhcss/mapsu/documents/10873.pdf [Accessed 19 January 2009].
    • Queensland health policy/guidelines
  • 25
    • 67651045642 scopus 로고    scopus 로고
    • Western Australian Therapeutics Advisory Group WATAG, Available from:, Accessed 19 January 2009
    • Western Australian Therapeutics Advisory Group (WATAG). Western Australia drug evaluation panel. Available from: http://www.watag.org.au/wadep/index.cfm [Accessed 19 January 2009].
    • Western Australia drug evaluation panel
  • 26
    • 33847283373 scopus 로고    scopus 로고
    • Prioritising drug and therapeutics committee (DTC) decisions: a national survey
    • Tan E.L., Day R.O., and Brien J.A. Prioritising drug and therapeutics committee (DTC) decisions: a national survey. Pharmacy World and Science 29 (2007) 90-96
    • (2007) Pharmacy World and Science , vol.29 , pp. 90-96
    • Tan, E.L.1    Day, R.O.2    Brien, J.A.3
  • 27
    • 42149128313 scopus 로고    scopus 로고
    • Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand
    • James P.R. Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand. The Medical Journal of Australia 188 (2008) 26
    • (2008) The Medical Journal of Australia , vol.188 , pp. 26
    • James, P.R.1
  • 28
    • 0029101478 scopus 로고
    • A purchaser perspective of managing new drugs: interferon beta as a case study
    • Walley T., and Barton S. A purchaser perspective of managing new drugs: interferon beta as a case study. British Medical Journal 311 (1995) 796-799
    • (1995) British Medical Journal , vol.311 , pp. 796-799
    • Walley, T.1    Barton, S.2
  • 29
    • 0028295017 scopus 로고
    • Hard times for hospital administrators. The problem of resource allocation
    • Komesaroff P. Hard times for hospital administrators. The problem of resource allocation. Medical Journal of Australia 160 (1994) 468-471
    • (1994) Medical Journal of Australia , vol.160 , pp. 468-471
    • Komesaroff, P.1
  • 30
    • 34848902310 scopus 로고    scopus 로고
    • Priority-setting and hospital strategic planning: a qualitative case study
    • Martin D., Shulman K., Santiago-Sorrell P., and Singer P. Priority-setting and hospital strategic planning: a qualitative case study. Critical Care Medicine 31 (2003) 197-201
    • (2003) Critical Care Medicine , vol.31 , pp. 197-201
    • Martin, D.1    Shulman, K.2    Santiago-Sorrell, P.3    Singer, P.4
  • 31
    • 21444443481 scopus 로고    scopus 로고
    • Prioritizing health-care funding: all things considered
    • Campbell D. Prioritizing health-care funding: all things considered. Internal Medicine Journal 35 (2005) 379-381
    • (2005) Internal Medicine Journal , vol.35 , pp. 379-381
    • Campbell, D.1
  • 32
    • 0030089572 scopus 로고    scopus 로고
    • Economics, values and health care reform
    • Fuchs V. Economics, values and health care reform. The American Economic Review 86 (1996) 1-24
    • (1996) The American Economic Review , vol.86 , pp. 1-24
    • Fuchs, V.1
  • 33
    • 67651029867 scopus 로고    scopus 로고
    • Hospital's cost-shifting exposes bid to balance books
    • Sydney
    • Parnell S. Hospital's cost-shifting exposes bid to balance books. The Australian. Sydney, 2007.
    • (2007) The Australian
    • Parnell, S.1
  • 37
    • 33845911971 scopus 로고    scopus 로고
    • Can we deny patients expensive drugs?
    • Kaye K.I., Lu Y., and Day R.O. Can we deny patients expensive drugs?. Australian Prescriber 29 (2006) 146-148
    • (2006) Australian Prescriber , vol.29 , pp. 146-148
    • Kaye, K.I.1    Lu, Y.2    Day, R.O.3
  • 38
    • 0034715904 scopus 로고    scopus 로고
    • Accountability for reasonableness
    • Daniels N. Accountability for reasonableness. BMJ 321 (2000) 1300-1301
    • (2000) BMJ , vol.321 , pp. 1300-1301
    • Daniels, N.1
  • 39
    • 67651017380 scopus 로고    scopus 로고
    • NSW Therapeutic Advisory Group TAG, TAG, high cost drugs working group. Available from:, Accessed
    • NSW Therapeutic Advisory Group (TAG). NSW therapeutic Advisory group (TAG): high cost drugs working group. Available from: http://www.ciap.health.nsw.gov.au/nswtag/high_cost_drugs-wp.html [Accessed].
    • NSW therapeutic Advisory group
  • 40
    • 67651014278 scopus 로고    scopus 로고
    • NSW Department of Health, Available from:, Accessed 19 January 2009
    • NSW Department of Health. Medicine-evaluation of medicines for use in public hospitals. Available from: http://www.health.nsw.gov.au/policies/pd/2008/pdf/PD2008_037.pdf [Accessed 19 January 2009].
    • Medicine-evaluation of medicines for use in public hospitals


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.